カテゴリー： 世界, 医療/バイオ, Research Dive

世界の外傷性脳損傷（TBI）分析市場2022年-2031年：エンドユーザー別（病院、診断センター、その他）、診断種類別（CTスキャン、MRI、電子機器、頭蓋内圧モニタリング、脳組織酸素分圧（pBrO2）、その他）

【英語タイトル】Traumatic Brain Injuries Assessment Market, by End-user (Hospital, Diagnostics Center, and Others) and Diagnostic Type (CT-Scan, MRI, Electronics, Intracranial Pressure Monitoring, Partial Pressure of Oxygen in Brain Tissue (pBrO2), and Others) Global Opportunity Analysis and Industry Forecast, 2022-2031

Research Diveが出版した調査資料（RDV23MA025）・商品コード：RDV23MA025
・発行会社（調査会社）：Research Dive
・発行日：2022年12月13日
・ページ数：250
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：生命科学
◆販売価格オプション（消費税別）
Single UserUSD5,700 ⇒換算￥866,400見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算￥1,322,400見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算￥1,626,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Research Dive社の本調査レポートでは、世界の外傷性脳損傷（TBI）分析市場規模が2021年9,570百万ドルから2031年には18,373.6百万ドルに達し、年平均7%成長すると予測しています。本レポートは、外傷性脳損傷（TBI）分析の世界市場について調査を行い、調査手法、調査範囲、エグゼクティブサマリー、市場概要、エンドユーザー別（病院、診断センター、その他）分析、診断種類別（CTスキャン、MRI、電子機器、頭蓋内圧モニタリング、脳組織酸素分圧（pBrO2）、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況などの項目をまとめています。なお、企業情報には、Integra Lifesciences, BioDirection, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta.などが含まれています。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界の外傷性脳損傷（TBI）分析市場規模：エンドユーザー別
- 病院における市場規模
- 診断センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の外傷性脳損傷（TBI）分析市場規模：診断種類別
- CTスキャンの市場規模
- MRIの市場規模
- 電子機器の市場規模
- 頭蓋内圧モニタリンの市場規模
- その他診断の市場規模
・世界の外傷性脳損傷（TBI）分析市場規模：地域別
- 北米の外傷性脳損傷（TBI）分析市場規模
- ヨーロッパの外傷性脳損傷（TBI）分析市場規模
- アジア太平洋の外傷性脳損傷（TBI）分析市場規模
- 中南米の外傷性脳損傷（TBI）分析市場規模
- 中東/アフリカの外傷性脳損傷（TBI）分析市場規模
・競争状況
・企業情報

According to Research Dive analysis, the global traumatic brain injuries assessment market is anticipated to generate a revenue of $18,373.6 million by 2031, growing from $9,570 million in 2021, at a healthy CAGR of 7%.

COVID-19 Impact on the Traumatic Brain Injuries Assessment Market:
Nearly every business was impacted by the global public health emergency due to the COVID-19 pandemic. The long-term impacts are expected to have an influence on industry growth during the forecast period. In order to assure the inclusion of underlying COVID-19 concerns and potential future directions, the continuous study expands upon the research approach. The report provides information on COVID-19 taking into account changes in consumer demand & behavior, buying habits, supply chain rerouting, dynamics of contemporary market forces, and significant government initiatives. Insights, analyses, projections, and forecasts are provided in the updated study, which takes the market impact of COVID-19 into account.
The COVID-19 pandemic had a significant influence on scientific research related to traumatic brain injuries (TBIs). Experimental and clinical investigations either slowed down or stopped, and resources were redistributed, leading to a “lost year” for the TBI field. The pandemic can, nevertheless, act as a turning point. This study outlines the philosophical and technological lessons that can be drawn from the COVID-19 pandemic to improve the categorization, diagnostic, and treatment effectiveness of TBIs.

Traumatic Brain Injuries Assessment MarketAnalysis:
It is anticipated that the increase in TBI cases from assaults, vehicle accidents, and sports injuries will fuel market growth during the forecast period. Demand for TBI evaluation and management devices is anticipated to increase due to a growing desire for less intrusive neuro therapies, which decrease pain and infection risk as well as allow quicker recovery. The market is projected to expand as a result of the increasing number of initiatives and programs connected to brain injuries being implemented by governments around the world. For instance, the Brain Injury Association of America (BIAA) runs a national public awareness campaign each year in March to emphasize the need for addressing the impacts of brain injuries.

Poor outcomes in mild, moderate, and severe TBI in both the adult and pediatric populations are linked to a number of variables. These elements can be divided into two categories: Those that are fixed at the time of the injury and those that are intervenable (i.e., secondary injuries). The latter cannot be affected by care received later, although the former offers predictive information.

TBI affects 2% of the population in Canada and accounts for 18,000 hospital admissions each year, according to the most recent statistics provided by Brain Injury Canada. In addition, according to the same source and data as above, In Canada, TBI affects 500 people out of every 100,000 people each year, or approximately165,000 people. 456 people are harmed every day, which means one person in every three minutes. The prevalence of TBIs is rising, which is increasing the need for TBI assessment tools. These factors will boost the market’s overall growth during the forecast period.

On the basis of end-user, the hospital segment is predicted to show the fastest growth rate. Professional neurologists use high-tech equipment in hospitals, which is anticipated to accelerate the segment’s expansion during the forecast period.
On the basis of diagnostic type, CT-Scan is expected to be the most dominant segment. A CT scan can immediately identify fractures and reveal signs of bleeding (hemorrhage), blood clots (hematomas), bruised (contusions), and swollen (edema) brain tissue.
On the basis of region, North America is growing due to the presence of well-established healthcare facilities and the availability of the latest treatment procedures region’s existence of reputable medical institutions, growing government initiatives, awareness campaigns for brain injuries, and a high prevalence of traumatic brain injuries.
The companies involved in the global traumatic brain injuries assessment market are Integra Lifesciences, BioDirection, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on global traumatic brain injuries assessment market

3.Executive Summary

4.Market Overview

4.1.Introduction
4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental

4.7.Impact of COVID-19 on traumatic brain injuries assessment market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.Traumatic Brain Injuries Assessment Market Analysis, by End-User

5.1.Overview
5.2.Hospital

5.2.1.Definition, key trends, growth factors, and opportunities
5.2.2.Market size analysis, by region
5.2.3.Market share analysis, by country

5.3.Diagnostics Center

5.3.1.Definition, key trends, growth factors, and opportunities
5.3.2.Market size analysis, by region
5.3.3.Market share analysis, by country

5.4.Others

5.4.1.Definition, key trends, growth factors, and opportunities
5.4.2.Market size analysis, by region
5.4.3.Market share analysis, by country

5.5.Research Dive Exclusive Insights

5.5.1.Market attractiveness
5.5.2.Competition heatmap

6.Traumatic Brain Injuries Assessment Market Analysis, by Diagnostic Type

6.1.CT-Scan

6.1.1.Definition, key trends, growth factors, and opportunities
6.1.2.Market size analysis, by region
6.1.3.Market share analysis, by country

6.2.MRI

6.2.1.Definition, key trends, growth factors, and opportunities
6.2.2.Market size analysis, by region
6.2.3.Market share analysis, by country

6.3.Intracranial Pressure Monitoring

6.3.1.Definition, key trends, growth factors, and opportunities
6.3.2.Market size analysis, by region
6.3.3.Market share analysis, by country

6.4.Partial Pressure of Oxygen in Brain Tissue (pBrO2)

6.4.1.Definition, key trends, growth factors, and opportunities
6.4.2.Market size analysis, by region
6.4.3.Market share analysis, by country

6.5.Others

6.5.1.Definition, key trends, growth factors, and opportunities
6.5.2.Market size analysis, by region
6.5.3.Market share analysis, by country

6.6.Research Dive Exclusive Insights

6.6.1.Market attractiveness
6.6.2.Competition heatmap

7.Traumatic Brain Injuries Assessment Market, by Region

7.1.North America

7.1.1.U.S.

7.1.1.1.Market size analysis, by End-User
7.1.1.2.Market size analysis, by Diagnostic type

7.1.2.Canada

7.1.2.1.Market size analysis, by End-User
7.1.2.2.Market size analysis, by Diagnostic type

7.1.3.Mexico

7.1.3.1.Market size analysis, by End-User
7.1.3.2.Market size analysis, by Diagnostic type

7.1.4.Research Dive Exclusive Insights

7.1.4.1.Market attractiveness
7.1.4.2.Competition heatmap

7.2.Europe

7.2.1.Germany

7.2.1.1.Market size analysis, by End-User
7.2.1.2.Market size analysis, by Diagnostic type

7.2.2.UK

7.2.2.1.Market size analysis, by End-User
7.2.2.2.Market size analysis, by Diagnostic type

7.2.3.France

7.2.3.1.Market size analysis, by End-User
7.2.3.2.Market size analysis, by Diagnostic type

7.2.4.Spain

7.2.4.1.Market size analysis, by End-User
7.2.4.2.Market size analysis, by Diagnostic type

7.2.5.Italy

7.2.5.1.Market size analysis, by End-User
7.2.5.2.Market size analysis, by Diagnostic type

7.2.6.Rest of Europe

7.2.6.1.Market size analysis, by End-User
7.2.6.2.Market size analysis, by Diagnostic type

7.2.7.Research Dive Exclusive Insights

7.2.7.1.Market attractiveness
7.2.7.2.Competition heatmap

7.3.Asia Pacific

7.3.1.China

7.3.1.1.Market size analysis, by End-User
7.3.1.2.Market size analysis, by Diagnostic type

7.3.2.Japan

7.3.2.1.Market size analysis, by End-User
7.3.2.2.Market size analysis, by Diagnostic type

7.3.3.India

7.3.3.1.Market size analysis, by End-User
7.3.3.2.Market size analysis, by Diagnostic type

7.3.4.Australia

7.3.4.1.Market size analysis, by End-User
7.3.4.2.Market size analysis, by Diagnostic type

7.3.5.South Korea

7.3.5.1.Market size analysis, by End-User
7.3.5.2.Market size analysis, by Diagnostic type

7.3.6.Rest of Asia Pacific

7.3.6.1.Market size analysis, by End-User
7.3.6.2.Market size analysis, by Diagnostic type

7.3.7.Research Dive Exclusive Insights

7.3.7.1.Market attractiveness
7.3.7.2.Competition heatmap

7.4.LAMEA

7.4.1.Brazil

7.4.1.1.Market size analysis, by End-User
7.4.1.2.Market size analysis, by Diagnostic type

7.4.2.Saudi Arabia

7.4.2.1.Market size analysis, by End-User
7.4.2.2.Market size analysis, by Diagnostic type

7.4.3.UAE

7.4.3.1.Market size analysis, by End-User
7.4.3.2.Market size analysis, by Diagnostic type

7.4.4.South Africa

7.4.4.1.Market size analysis, by End-User
7.4.4.2.Market size analysis, by Diagnostic type

7.4.5.Rest of LAMEA

7.4.5.1.Market size analysis, by End-User
7.4.5.2.Market size analysis, by Diagnostic type

7.4.6.Research Dive Exclusive Insights

7.4.6.1.Market attractiveness
7.4.6.2.Competition heatmap

8.Competitive Landscape

8.1.Top winning strategies, 2021

8.1.1.By strategy
8.1.2.By year

8.2.Strategic overview
8.3.Market share analysis, 2021

9.Company Profiles

9.1.Integra Life science

9.1.1.Overview
9.1.2.Business segments
9.1.3.Product portfolio
9.1.4.Financial performance
9.1.5.Recent developments
9.1.6.SWOT analysis

9.2.Bio Direction, Inc.

9.2.1.Overview
9.2.2.Business segments
9.2.3.Product portfolio
9.2.4.Financial performance
9.2.5.Recent developments
9.2.6.SWOT analysis

9.3.Nihon Kohden Corp.

9.3.1.Overview
9.3.2.Business segments
9.3.3.Product portfolio
9.3.4.Financial performance
9.3.5.Recent developments
9.3.6.SWOT analysis

9.4.Comp medics Ltd.

9.4.1.Overview
9.4.2.Business segments
9.4.3.Product portfolio
9.4.4.Financial performance
9.4.5.Recent developments
9.4.6.SWOT analysis

9.5.InfraScan, Inc.

9.5.1.Overview
9.5.2.Business segments
9.5.3.Product portfolio
9.5.4.Financial performance
9.5.5.Recent developments
9.5.6.SWOT analysis

9.6.Oculogica

9.6.1.Overview
9.6.2.Business segments
9.6.3.Product portfolio
9.6.4.Financial performance
9.6.5.Recent developments
9.6.6.SWOT analysis

9.7.Raumedic AG

9.7.1.Overview
9.7.2.Business segments
9.7.3.Product portfolio
9.7.4.Financial performance
9.7.5.Recent developments
9.7.6.SWOT analysis

9.8.Koninklijke Philips N.V,

9.8.1.Overview
9.8.2.Business segments
9.8.3.Product portfolio
9.8.4.Financial performance
9.8.5.Recent developments
9.8.6.SWOT analysis

9.9.Boston Scientific Corporation,

9.9.1.Overview
9.9.2.Business segments
9.9.3.Product portfolio
9.9.4.Financial performance
9.9.5.Recent developments
9.9.6.SWOT analysis

9.10.Elekta

9.10.1.Overview
9.10.2.Business segments
9.10.3.Product portfolio
9.10.4.Financial performance
9.10.5.Recent developments
9.10.6.SWOT analysis

10.Appendix

10.1.Parent & peer market analysis
10.2.Premium insights from industry experts
10.3.Related reports



★調査レポート[世界の外傷性脳損傷（TBI）分析市場2022年-2031年：エンドユーザー別（病院、診断センター、その他）、診断種類別（CTスキャン、MRI、電子機器、頭蓋内圧モニタリング、脳組織酸素分圧（pBrO2）、その他）] (コード：RDV23MA025)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の外傷性脳損傷（TBI）分析市場2022年-2031年：エンドユーザー別（病院、診断センター、その他）、診断種類別（CTスキャン、MRI、電子機器、頭蓋内圧モニタリング、脳組織酸素分圧（pBrO2）、その他）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の外傷性脳損傷（TBI）分析市場2021-2031：エンドユーザー別（病院、診断センター、その他）、診断種類別（CTスキャン、MRI、頭蓋内圧モニタリング、脳組織内酸素分圧（pBrO2）、その他）
  • 世界の外傷性脳損傷（TBI）評価＆管理装置市場（2023-2030）：装置別（イメージング装置、モニタリング装置）、技術別、エンドユーザー別（診断センター）、地域別
  • 世界の3D細胞培養市場2022年-2031年：製品別（スキャフォールドベース3D細胞培養、スキャフォールドなし3D細胞培養、マイクロ流体生体機能チップモデル）、用途別（がん研究、幹細胞研究、創薬＆開発、再生医療）、エンドユーザー別（バイオテクノロジー＆製薬会社、受託研究所、病院、診断センター、学術機関）
  • 世界のCアーム市場2021年-2031年：種類別（携帯型Cアーム、固定型Cアーム）、用途別（循環器内科、消化器内科、神経科、整形外科＆外傷、腫瘍、その他）、エンドユーザー別（病院、診断センター、専門診療所）
  • 世界の医療機器洗浄市場2021年-2031年：機器別（クリティカル、セミクリティカル、ノンクリティカル）、技術別（洗浄、消毒、滅菌、オートクレーブ）、EPA分類別（高レベル、中レベル、低レベル）、エンドユーザー別（病院、歯科クリニック、診断センター、その他）
  • 世界の携帯型トモグラフィー市場2021年-2031年：技術別（ハイスライススキャナー、ミッドスライススキャナー、ロースライススキャナー、その他（コーンビーム））、用途別（腫瘍、神経病、心臓病、血管、その他（筋骨格、病理学、整形外科））、エンドユーザー別（病院、診療所、診断センター、学術研究、外来センター）
  • 世界の免税店市場2022年-2031年：製品種類別（香水&化粧品、電子機器、ワイン&スピリッツ、食品、菓子&ケータリング、タバコ、高級品、その他）、販売チャネル別（空港、クルーズ船、鉄道駅、国境、ダウンタウン&ホテルショップ）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）
  • 世界の卵巣がん診断市場2023-2030：診断種類別（画像診断、血液検査、生検、その他）、がん種類別（上皮性腫瘍、間質細胞腫瘍、胚細胞腫瘍、その他）、エンドユーザー別（病院研究所、がん診断センター、研究機関、その他）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆